Categories: News

Arbor Biotechnologies to Present at the Stifel 2023 Tailoring Genes: Genetic Medicines Day

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

CAMBRIDGE, Mass., May 23, 2023 (GLOBE NEWSWIRE) — Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced Devyn Smith, Ph.D., Arbor’s Chief Executive Officer, will present at the Stifel 2023 Tailoring Genes: Genetic Medicines Day. The event will be held on Tuesday, May 30, 2023, and will be livestreamed.

The following are specific details regarding Arbor Biotechnologies’ presentation at the conference:

Event: Stifel 2023 Tailoring Genes: Genetic Medicines Day
Date: Tuesday, May 30, 2023
Time: 9:10 a.m. ET
Location: Virtual

A webcast of the Stifel 2023 Tailoring Genes: Genetic Medicines Day presentation will be accessible through the Press Releases page of the Company’s website at www.arbor.bio, with a replay available for 90 days following the event.

About Arbor Biotechnologies®
Arbor Biotechnologies is a next-generation gene editing company focused on discovering and developing potentially curative genomic medicines, with the most extensive toolbox of proprietary genomic editors in the industry to date. Founded by Feng Zhang, David Walt, David Scott, and Winston Yan, our proprietary discovery engine is focused on discovering and evolving technologies that enable gene knockout, RT editing, precise excisions and large insertions into endogenous loci. Leveraging our wholly owned nucleases as the chassis for genetic modification, we have the unique ability to work backward from disease pathology and choose the optimal editors or combination of editors for the disease in question, with a focus on areas of high unmet need. As Arbor continues to advance its pipeline toward the clinic with an initial focus in liver and CNS disease, the Company has also secured several partnerships around gene editing and ex vivo cell therapy programs to broaden the reach of its novel nuclease technology. For more information, please visit: arbor.bio

Media
Amy Bonanno, Solebury Strategic Communications
abonanno@soleburystrat.com
914-450-0349

Staff

Recent Posts

Best Skin Tag Remover 2025: Revitag Review & Top Skin Tag Removal Tips

Looking for the best skin tag remover in 2025? Discover how Revitag works, plus expert…

20 hours ago

Best Probiotic for Bloating, Gas, and Constipation: Top Probiotic Supplements for Gut Health to Reduce Bloating, Indigestion & Flatulence (YourBiology)

The best probiotics for bloating and gas include strains like Lactobacillus rhamnosus GG, Lactobacillus acidophilus,…

20 hours ago

Best Vyvanse Alternative Over the Counter for ADHD – Natural Vyvanse Substitute – Noocube

NooCube NooCube London, May 10, 2025 (GLOBE NEWSWIRE) -- Vyvanse is a prescription medication that…

20 hours ago

MEDVi Under Review: Best GLP-1 Semaglutide & Terzepatide Compound Solution for Personalized Weight Loss

A Comprehensive Review of MEDVi’s Personalized GLP-1 Weight Loss Solutions Featuring Affordable Compounded Semaglutide and…

20 hours ago

Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL Congress 2025

Analysis of EFX results with AI-based digital pathology underscores the potential value in evaluating histopathology…

20 hours ago

Sumatra Slim Belly Tonic Reviews: 2025 Real User Reviews Analyzed & Verified (Blue Tonic for Weight Loss)

LOS ANGELES, May 10, 2025 (GLOBE NEWSWIRE) -- Losing weight these days can feel more…

2 days ago